StemWave

04/27/2026

Hear from StemWave Clinical Advisor Dr. Morris on why providers who are on the fence should see it for themselves. Once it clicks, the difference shows up quickly in your patients and in your practice.

04/23/2026

Chiropractic philosophy is simple: help the body do what it's already trying to do.

Dr. Clint Bennion, DC has practiced that for years. He's also watched patients avoid injections, avoid opioids, avoid surgery — sometimes successfully, more often times not.

StemWave became part of what he offers. Not because of the pitch. Because of what happened after.

"The support with StemWave has been so good that I can confidently just tell people — just do it."

🎧 Webinar clip — Dr. Clint Bennion, DC | Bettendorf, Iowa

04/22/2026

Spring is back... and so is your knee pain. StemWave has helped thousands across the country FINALLY get back to doing what they love. Click the link in our bio to find a provider near you.

04/20/2026

If your growth depends on squeezing in more appointments, it’s not growth. It’s just a busier version of the same problem.

This is the math most clinics are working with right now:

• $75/session → ~7 extra patients per day
• $50/session → ~10 extra patients per day
• $45/session → ~11 extra patients per day

And that’s before drop-off.

Realistically, 1–2 out of every 5 patients won’t complete a full plan. So the number you actually need is even higher.

More volume sounds like the answer… until your schedule fills up and nothing really changes.

At a certain point, it’s not about working harder or stacking more visits.

It’s about how your treatments are structured, how long they take, and what each visit is actually worth to your practice.

04/17/2026

Dr. Wagner had talked to other companies before choosing StemWave. What stood out wasn't the technology, it was a text from the director of sales asking if he had what he needed.
That kind of relationship is rare in this space. It's also not an accident.

04/16/2026

"It made practice fun again." 💡

04/16/2026

Not every StemWave provider is a PT, MD, or chiropractor.

Dr. Sarah Thomas is a doctor of acupuncture in coastal Georgia. Same patient outcomes. Different practice entirely.

Full Q&A below ⬇️ worth a read if you're in a specialized practice or just curious how this translates outside the traditional provider profile.

Dr. Sarah Thomas added focused acoustic wave therapy to her acupuncture practice. Here's what changed — clinically and financially.

04/14/2026

LINK IN COMMENTS: Most providers who ask about StemWave are chiropractors or PTs.

Dr. Sarah Thomas is neither.

She's a doctor of acupuncture in a coastal Georgia town, treating an aging, active patient base that's already been through the western medicine circuit — surgeries, injections, replacements. Patients who've tried everything.

Six months after adding focused acoustic wave therapy to her practice, her monthly revenue had more than doubled. More importantly, she had patients leaving without canes they'd walked in with.

Her full story is on the blog. Link in the comments.

__

Intended Use: The Modus-F by StemWave, utilizing Cellular Response Technology (CRT), is a Class I FDA listed device intended for use in addressing minor aches and pains in accordance with the User Manual (IFU). The content provided is for informational purposes only and does not constitute medical advice. Results discussed may not be typical and are not a guarantee of outcome. Consult a qualified healthcare professional for personalized medical advice and treatment.

The business and financial results described reflect one individual provider’s experience and are not typical. Practice revenue, patient volume, and business outcomes vary significantly based on practice type, geography, patient demographics, marketing investment, and other factors. This is not a guarantee of financial or business performance. StemWave makes no representations regarding expected income or business results.

04/10/2026

We'll take being compared to a Ferrari any day.

04/09/2026

The providers who get the most out of StemWave are the ones willing to get honest about where they are and where they want to go.

04/06/2026

Bri talks to providers about this device every single day. This time, she finally felt it herself.



--
The experience described reflects one individual's results. Clinical outcomes vary from patient to
patient. StemWave's Modus-F is a Class I FDA listed device intended for use in addressing minor
aches and pains per its Indications for Use. These results are not typical and are not a guarantee of
clinical outcome. Individual results depend on a variety of factors including condition severity,
treatment protocol, and overall health status. Consult a qualified healthcare professional before
beginning any treatment.

04/02/2026

Did you know? StemWave's applicator head is engineered to reach areas of the body that most devices can't access cleanly.

Bony prominences. Joint lines. Tendon attachment sites. The geometry of the head makes precise contact possible across virtually every region of the body — which is why providers are using it across their entire patient roster, not just a single use case.

For patients dealing with minor aches and pains that haven't responded to anything else, that reach matters.

And for providers, it means one device can serve far more of the practice than they expected — often opening up a service offering they weren't able to provide before.

Link in our profile to learn more about the engineering behind StemWave.

------
Intended Use: The Modus-F by StemWave, utilizing Cellular Response Technology (CRT), is a Class I FDA listed device intended for use in addressing minor aches and pains in accordance with the User Manual (IFU). Results are not typical and are not a guarantee of outcome.